BioWorld MedTech

May 24, 2019

View Archived Issues

Pi-Cardia's Leaflex treatment improves aortic stenosis more than balloon valvuloplasty

Electrocore scores with VNS device for headache in U.K. innovation program

Insulin micropump maker Cellnovo files for bankruptcy

Fountain Healthcare closes its third fund at $132M

Baylis' large access, transseptal dilator for stroke and angioplasty unveiled in U.S.

Holiday notice

Other news to note

Appointments and advancements

Daily M&A

Financings

Regulatory front

Product clinical data for May 23, 2019

Product regulatory actions for May 23, 2019

BioWorld MedTech's Diagnostics Extra

Medtronic beats challenges to shine in Q4

Medtronic plc, of Dublin, reported financial results for its fiscal year and fourth quarter 2019, with emerging markets growing 12% this quarter, representing 16% of the company's revenue. Read More

Verily partners with Novartis, Otsuka, Pfizer and Sanofi to transform clinical trial data collection

Today's news in brief

BioWorld

BioWorld briefs for July 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 18, 2025.

Biocon wins first FDA interchangeable label of Novolog biosimilar

BioWorld

The U.S. FDA on July 15 cleared Biocon Biologics Ltd.’s Kirsty (insulin aspart-xjhz) as the first and only interchangeable biosimilar product referencing Novo...

Adcom agrees with FDA: Otsuka’s PTSD treatment needs more study

BioWorld

In a 10-1 vote, the U.S. FDA’s Psychopharmacologic Drugs Advisory Committee said Otsuka Pharmaceutical Co. Ltd.’s studies of its combination post-traumatic stress...

Proteomics finds surprise commonalities as well as differences in neurodegenerative diseases

BioWorld

The switch will be flicked today to make the world’s largest dementia-related proteomics dataset freely available to researchers, at the same time as members of...